- Home
- SYRE vs NSSC Comparison
SYRE vs NSSC Comparison
Compare SYRE & NSSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- NSSC
- Stock Information
- Founded
- SYRE 2013
- NSSC 1969
- Country
- SYRE United States
- NSSC United States
- Employees
- SYRE N/A
- NSSC N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- NSSC Telecommunications Equipment
- Sector
- SYRE Health Care
- NSSC Telecommunications
- Exchange
- SYRE Nasdaq
- NSSC Nasdaq
- Market Cap
- SYRE 1.1B
- NSSC 1.1B
- IPO Year
- SYRE 2016
- NSSC N/A
- Fundamental
- Price
- SYRE $16.23
- NSSC $42.97
- Analyst Decision
- SYRE Strong Buy
- NSSC Strong Buy
- Analyst Count
- SYRE 6
- NSSC 6
- Target Price
- SYRE $57.60
- NSSC $38.50
- AVG Volume (30 Days)
- SYRE 681.2K
- NSSC 417.2K
- Earning Date
- SYRE 11-06-2025
- NSSC 11-03-2025
- Dividend Yield
- SYRE N/A
- NSSC 1.30%
- EPS Growth
- SYRE N/A
- NSSC N/A
- EPS
- SYRE N/A
- NSSC 1.19
- Revenue
- SYRE N/A
- NSSC $181,621,000.00
- Revenue This Year
- SYRE N/A
- NSSC $10.78
- Revenue Next Year
- SYRE N/A
- NSSC $8.21
- P/E Ratio
- SYRE N/A
- NSSC $36.10
- Revenue Growth
- SYRE N/A
- NSSC N/A
- 52 Week Low
- SYRE $10.91
- NSSC $19.00
- 52 Week High
- SYRE $40.26
- NSSC $45.03
- Technical
- Relative Strength Index (RSI)
- SYRE 52.04
- NSSC 64.01
- Support Level
- SYRE $15.87
- NSSC $42.25
- Resistance Level
- SYRE $17.18
- NSSC $43.48
- Average True Range (ATR)
- SYRE 0.88
- NSSC 1.01
- MACD
- SYRE 0.08
- NSSC -0.36
- Stochastic Oscillator
- SYRE 70.65
- NSSC 46.21
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.